<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39552883</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2072-1439</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>31</Day></PubDate></JournalIssue><Title>Journal of thoracic disease</Title><ISOAbbreviation>J Thorac Dis</ISOAbbreviation></Journal><ArticleTitle>Analysis of <i>Mycoplasma pneumoniae</i> pneumonia and viral coinfection in southern Guangzhou after the COVID-19 pandemic.</ArticleTitle><Pagination><StartPage>6789</StartPage><EndPage>6798</EndPage><MedlinePgn>6789-6798</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.21037/jtd-24-729</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED"><i>Mycoplasma pneumoniae</i> (MP) has recently become an important pathogen of respiratory infection in both children and adults. The objective of this study was to investigate the detection rate of MP and clinical features of viral coinfection in <i>Mycoplasma pneumoniae</i> pneumonia (MPP) after the coronavirus disease 2019 (COVID-19) pandemic in southern Guangzhou.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We reviewed 3,094 patients with respiratory infection who visited the respiratory medicine and pediatrics department from October 2023 to January 2024. Patients underwent polymerase chain reaction (PCR) or immunoglobulin M (IgM) serology for MP, influenza virus (IFV), respiratory syncytial virus (RSV), adenovirus (ADV) and enterovirus (EV). We further compared the clinical, laboratory, and imaging findings of the MPP patients with and without viral coinfection. In order to identify the significant association with viral coinfection in MPP, multivariable logistic regression analysis was performed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">MP infection was identified in 746 (36.69%) children and 140 (13.20%) adults, and there were 308 (41.29%) children and 76 (54.29%) adults with MPP. Eighty-four (27.27%) children and 7 (5.0%) adults with MPP had viral coinfection. Viral coinfection including MPP-RSV (4.22%), MPP-ADV (4.22%), MPP-EV (7.14%) and MPP-IFV (11.68%) was identified in children. These patients had a higher frequency of fever, higher white blood cell, higher concentration of C-reactive protein and procalcitonin, and higher proportion of lactate dehydrogenase (LDH) at greater than 250 U/L. Imaging feature of consolidation and air bronchogram sign was observed in both MPP and viral coinfection. Multivariable analysis showed fever (adjusted odds ratio, 3.46; 95% confidence interval, 1.02-11.74; P=0.047) and elevated procalcitonin of greater than 5 ng/mL (adjusted odds ratio, 3.17; 95% confidence interval: 1.50-6.72; P=0.003) as the factors associated with the viral coinfection, suggesting that viral infections could aggravate the primary MP infection or predispose patients to secondary bacterial infection.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Viral coinfection in MPP was common after the COVID-19 pandemic in southern Guangzhou. Increase in procalcitonin should be considered as a possibility of viral coinfection in children with MPP. This finding suggests the need for viral test in children with elevated procalcitonin in MPP, which could help clinicians identify viral coinfection at an early stage and provide timely antiviral intervention.</AbstractText><CopyrightInformation>2024 AME Publishing Company. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xiongting</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-5720-0762</Identifier><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Rong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mo</LastName><ForeName>Di</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yinyan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Yuxiao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Mengzhang</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5130-0503</Identifier><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>J Thorac Dis</MedlineTA><NlmUniqueID>101533916</NlmUniqueID><ISSNLinking>2072-1439</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">Mycoplasma pneumoniae pneumonia (MPP)</Keyword><Keyword MajorTopicYN="N">viral coinfection</Keyword></KeywordList><CoiStatement>Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-24-729/coif). The authors report the funding from the Plan on Enhancing Scientific Research in GMU (No. 0803030072) and Guangdong Medical Science and Technology Research Fund (No. A2024432). The authors have no other conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>5</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39552883</ArticleId><ArticleId IdType="pmc">PMC11565328</ArticleId><ArticleId IdType="doi">10.21037/jtd-24-729</ArticleId><ArticleId IdType="pii">jtd-16-10-6789</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med 2015;372:835-45. 10.1056/NEJMoa1405870</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1405870</ArticleId><ArticleId IdType="pmc">PMC4697461</ArticleId><ArticleId IdType="pubmed">25714161</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev 2008;32:956-73. 10.1111/j.1574-6976.2008.00129.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2008.00129.x</ArticleId><ArticleId IdType="pubmed">18754792</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E, Kim CH, Lee YJ, et al. Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea. BMC Infect Dis 2020;20:132. 10.1186/s12879-020-4810-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-4810-9</ArticleId><ArticleId IdType="pmc">PMC7017508</ArticleId><ArticleId IdType="pubmed">32050912</ArticleId></ArticleIdList></Reference><Reference><Citation>Juv√©n T, Mertsola J, Waris M, et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J 2000;19:293-8. 10.1097/00006454-200004000-00006</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-200004000-00006</ArticleId><ArticleId IdType="pubmed">10783017</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowling BJ, Ali ST, Ng TWY, et al. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health 2020;5:e279-88. 10.1016/S2468-2667(20)30090-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(20)30090-6</ArticleId><ArticleId IdType="pmc">PMC7164922</ArticleId><ArticleId IdType="pubmed">32311320</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang QS, Wood T, Jelley L, et al. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Nat Commun 2021;12:1001. 10.1038/s41467-021-21157-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21157-9</ArticleId><ArticleId IdType="pmc">PMC7881137</ArticleId><ArticleId IdType="pubmed">33579926</ArticleId></ArticleIdList></Reference><Reference><Citation>von Hammerstein AL, Aebi C, Barbey F, et al. Interseasonal RSV infections in Switzerland - rapid establishment of a clinician-led national reporting system (RSV EpiCH). Swiss Med Wkly 2021;151:w30057. 10.4414/SMW.2021.w30057</Citation><ArticleIdList><ArticleId IdType="doi">10.4414/SMW.2021.w30057</ArticleId><ArticleId IdType="pubmed">34499459</ArticleId></ArticleIdList></Reference><Reference><Citation>Haapanen M, Renko M, Artama M, et al. The impact of the lockdown and the re-opening of schools and day cares on the epidemiology of SARS-CoV-2 and other respiratory infections in children - A nationwide register study in Finland. EClinicalMedicine 2021;34:100807. 10.1016/j.eclinm.2021.100807</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100807</ArticleId><ArticleId IdType="pmc">PMC8007090</ArticleId><ArticleId IdType="pubmed">33817612</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen SJ, Winn AK, Budd AP, et al. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic-United States, 2020-2021. Am J Transplant 2021;21:3481-6. 10.1111/ajt.16049</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16049</ArticleId><ArticleId IdType="pmc">PMC8653380</ArticleId><ArticleId IdType="pubmed">34624182</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer Sauteur PM, Beeton ML, Uldum SA, et al. Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021. Euro Surveill 2022;27:2100746. 10.2807/1560-7917.ES.2022.27.19.2100746</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2022.27.19.2100746</ArticleId><ArticleId IdType="pmc">PMC9101966</ArticleId><ArticleId IdType="pubmed">35551702</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Q, Xu BP, Shen KL. Effects of bacterial and viral co-infections of mycoplasma pneumoniae pneumonia in children: analysis report from Beijing Children's Hospital between 2010 and 2014. Int J Clin Exp Med 2015;8:15666-74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4658950</ArticleId><ArticleId IdType="pubmed">26629061</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim YK, Kweon OJ, Kim HR, et al. Impact of bacterial and viral coinfection in community-acquired pneumonia in adults. Diagn Microbiol Infect Dis 2019;94:50-4. 10.1016/j.diagmicrobio.2018.11.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2018.11.014</ArticleId><ArticleId IdType="pmc">PMC7126955</ArticleId><ArticleId IdType="pubmed">30578007</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YN, Zhang YF, Xu Q, et al. Infection and co-infection patterns of community-acquired pneumonia in patients of different ages in China from 2009 to 2020: a national surveillance study. Lancet Microbe 2023;4:e330-9. 10.1016/S2666-5247(23)00031-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(23)00031-9</ArticleId><ArticleId IdType="pubmed">37001538</ArticleId></ArticleIdList></Reference><Reference><Citation>Choo S, Lee YY, Lee E. Clinical significance of respiratory virus coinfection in children with Mycoplasma pneumoniae pneumonia. BMC Pulm Med 2022;22:212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9150047</ArticleId><ArticleId IdType="pubmed">35637540</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Lin L, Zhang N, et al. Adenovirus and Mycoplasma pneumoniae co-infection as a risk factor for severe community-acquired pneumonia in children. Front Pediatr 2024;12:1337786. 10.3389/fped.2024.1337786</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2024.1337786</ArticleId><ArticleId IdType="pmc">PMC10864498</ArticleId><ArticleId IdType="pubmed">38357505</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH, Kwon JH, Lee JY, et al. Clinical features of Mycoplasma pneumoniae coinfection and need for its testing in influenza pneumonia patients. J Thorac Dis 2018;10:6118-27. 10.21037/jtd.2018.10.33</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2018.10.33</ArticleId><ArticleId IdType="pmc">PMC6297417</ArticleId><ArticleId IdType="pubmed">30622783</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh JS, Choi JS, Lee YH, et al. The Relationships between Respiratory Virus Infection and Aminotransferase in Children. Pediatr Gastroenterol Hepatol Nutr 2016;19:243-50. 10.5223/pghn.2016.19.4.243</Citation><ArticleIdList><ArticleId IdType="doi">10.5223/pghn.2016.19.4.243</ArticleId><ArticleId IdType="pmc">PMC5234413</ArticleId><ArticleId IdType="pubmed">28090469</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Zhang Q, Du JL, et al. Correlation Between the Clinical Severity, Bacterial Load, and Inflammatory Reaction in Children with Mycoplasma Pneumoniae Pneumonia. Curr Med Sci 2020;40:822-8. 10.1007/s11596-020-2261-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11596-020-2261-6</ArticleId><ArticleId IdType="pmc">PMC7595045</ArticleId><ArticleId IdType="pubmed">33123897</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam S, Cohen AJ, Stahl Y, et al. Severe respiratory viral infection induces procalcitonin in the absence of bacterial pneumonia. Thorax 2020;75:974-81. 10.1136/thoraxjnl-2020-214896</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-214896</ArticleId><ArticleId IdType="pubmed">32826284</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanada S, Pirzadeh M, Carver KY, et al. Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia. Front Immunol 2018;9:2640. 10.3389/fimmu.2018.02640</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02640</ArticleId><ArticleId IdType="pmc">PMC6250824</ArticleId><ArticleId IdType="pubmed">30505304</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004;39:206-17. 10.1086/421997</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/421997</ArticleId><ArticleId IdType="pubmed">15307030</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X, Gu H, Wu R, et al. Chest imaging classification in Mycoplasma pneumoniae pneumonia is associated with its clinical features and outcomes. Respir Med 2024;221:107480. 10.1016/j.rmed.2023.107480</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2023.107480</ArticleId><ArticleId IdType="pubmed">38043865</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Sun R, Jia W, et al. Clinical Characteristics of Lung Consolidation with Mycoplasma pneumoniae Pneumonia and Risk Factors for Mycoplasma pneumoniae Necrotizing Pneumonia in Children. Infect Dis Ther 2024;13:329-43. 10.1007/s40121-023-00914-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-023-00914-x</ArticleId><ArticleId IdType="pmc">PMC10904708</ArticleId><ArticleId IdType="pubmed">38265626</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Chen Z, Gu W, et al. Viral and bacterial co-infection in hospitalised children with refractory Mycoplasma pneumoniae pneumonia. Epidemiol Infect 2018;146:1384-8. 10.1017/S0950268818000778</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268818000778</ArticleId><ArticleId IdType="pmc">PMC9133674</ArticleId><ArticleId IdType="pubmed">29970200</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>